subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate

object_name: myelodysplastic syndrome with single lineage dysplasia

tested_intervention: unsure


subject: CHEBI:44185

object_name: reactive angioendotheliomatosis


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: UNII:NU90V55F8I


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine


subject: PUBCHEM.COMPOUND:5339


subject: CHEBI:83766

subject_name: Olaparib

object_name: head and neck squamous cell carcinoma

tested_intervention: yes


subject: CHEBI:42588

subject_name: Fenretinide

object_name: Childhood Solid Neoplasm


subject: CHEBI:42588

object_name: Adult Solid Neoplasm


subject: CHEBI:42588

object_name: Solid Neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: chronic hepatitis C virus infection


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: neuroendocrine carcinoma


subject: UMLS:C3896806


subject: UMLS:C4048712

subject_name: factor IX complex

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human


subject: UMLS:C0593103

subject_name: Novoseven


subject: CHEBI:32599

object_name: cardiac arrest


subject: CHEBI:32599

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C2700272

subject_name: White Button Mushroom Extract

object_name: breast carcinoma


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: psoriasis


subject: UMLS:C5786909

subject_name: Yisui Shengxue Granule

object_name: Myelodysplasia


subject: UMLS:C5786909

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C5786909

object_name: myoclonic dystonia 11


subject: CHEBI:36704

subject_name: Imiquimod

object_name: mycosis fungoides


subject: UMLS:C5690584


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: hematopoietic and lymphoid system neoplasm


subject: PR:000016293

object_name: External causes of morbidity and mortality


subject: PR:000016293

object_name: Cross Infection


subject: PR:000016293

object_name: hypoglycemia


subject: PR:000016293

object_name: Blood glucose below reference range (finding)


subject: PR:000016293

object_name: Hypoglycemia, CTCAE


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: calcium metabolic disease


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: End-stage kidney disease (ESKD)


subject: CHEBI:50634

object_name: prostate carcinoma


subject: CHEBI:50634

object_name: prostate cancer


subject: CHEBI:50634

object_name: multiple endocrine neoplasia


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: PUBCHEM.COMPOUND:3367

object_name: Graft failure


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:231679

subject_name: ipilimumab

object_name: peritoneal carcinomatosis


subject: CHEBI:231679

object_name: Metastatic Cervical Carcinoma


subject: CHEBI:231679

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:231679

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:231679

object_name: Cervix carcinoma recurrent


subject: CHEBI:231679

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:231679

object_name: Recurrent Endometrial Cancer


subject: CHEBI:231679

object_name: Recurrent Malignant Female Reproductive System Neoplasm


subject: CHEBI:231679

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: CHEBI:231679

object_name: Recurrent ovarian cancer


subject: CHEBI:231679

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:231679

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:231679

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: CHEBI:231679

object_name: Platinum-Resistant Malignant Female Reproductive System Neoplasm


subject: CHEBI:231679

object_name: Platinum-Refractory Malignant Female Reproductive System Neoplasm


subject: CHEBI:231679

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:231679

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:231679

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:231679

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:231679

object_name: peritoneum cancer


subject: CHEBI:231679

object_name: retroperitoneal cancer


subject: CHEBI:231679

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:231679

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:231679

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: CHEBI:231679

object_name: Platinum-Refractory Ovarian Carcinoma


subject: CHEBI:231679

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab

object_name: peritoneal carcinomatosis


subject: CHEBI:231614

object_name: Metastatic Cervical Carcinoma


subject: CHEBI:231614

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:231614

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:231614

object_name: Cervix carcinoma recurrent


subject: CHEBI:231614

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:231614

object_name: Recurrent Endometrial Cancer


subject: CHEBI:231614

object_name: Recurrent Malignant Female Reproductive System Neoplasm


subject: CHEBI:231614

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: CHEBI:231614

object_name: Recurrent ovarian cancer


subject: CHEBI:231614

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:231614

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:231614

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: CHEBI:231614

object_name: Platinum-Resistant Malignant Female Reproductive System Neoplasm


subject: CHEBI:231614

object_name: Platinum-Refractory Malignant Female Reproductive System Neoplasm


subject: CHEBI:231614

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:231614

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:231614

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:231614

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:231614

object_name: peritoneum cancer


subject: CHEBI:231614

object_name: retroperitoneal cancer


subject: CHEBI:231614

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:231614

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:231614

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: CHEBI:231614

object_name: Platinum-Refractory Ovarian Carcinoma


subject: CHEBI:231614

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UMLS:C2346820

object_name: peritoneal carcinomatosis


subject: UMLS:C2346820

object_name: Metastatic Cervical Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Primary Peritoneal Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C2346820

object_name: Cervix carcinoma recurrent


subject: UMLS:C2346820

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Endometrial Cancer


subject: UMLS:C2346820

object_name: Recurrent Malignant Female Reproductive System Neoplasm


subject: UMLS:C2346820

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: UMLS:C2346820

object_name: Recurrent ovarian cancer


subject: UMLS:C2346820

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Ovarian Carcinoma


subject: UMLS:C2346820

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UMLS:C2346820

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: UMLS:C2346820

object_name: Platinum-Resistant Malignant Female Reproductive System Neoplasm


subject: UMLS:C2346820

object_name: Platinum-Refractory Malignant Female Reproductive System Neoplasm


subject: UMLS:C2346820

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2346820

object_name: Metastatic Fallopian Tube Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C2346820

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C2346820

object_name: peritoneum cancer


subject: UMLS:C2346820

object_name: retroperitoneal cancer


subject: UMLS:C2346820

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C2346820

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UMLS:C2346820

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: UMLS:C2346820

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UMLS:C2346820

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:41423

subject_name: Celecoxib

object_name: classic familial adenomatous polyposis


subject: CHEBI:41423

object_name: Adenomatous colonic polyposis


subject: UNII:MLU3LU3EVV

subject_name: Onasemnogene abeparvovec

object_name: proximal spinal muscular atrophy


subject: UMLS:C5140521

subject_name: onasemnogene abeparvovec-xioi

object_name: spinal muscular atrophy


subject: UMLS:C5140521


subject: CHEBI:157903

subject_name: Tyr-Cys

object_name: cystic fibrosis


subject: CHEBI:33353

subject_name: technetium atom


subject: UMLS:C0040642

subject_name: Transcobalamin


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: stroke disorder


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: cerebrovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Stroke (heart beat)


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Stroke, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Spasticity


subject: UMLS:C5706513

subject_name: Stapokibart

object_name: asthma


subject: PUBCHEM.COMPOUND:25127414

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:25127414

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:25127414

object_name: Metastatic non-small cell lung cancer


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: UNII:0ICW2LX8AS


subject: UNII:0ICW2LX8AS


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Poisoning by, adverse effect of and underdosing of benzodiazepines


subject: UMLS:C1527137

object_name: Benzodiazepine poisoning


subject: UMLS:C1527137

object_name: Benzodiazepines causing adverse effects in therapeutic use


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: polyneuropathy


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: malnutrition


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: congenital heart disease


subject: DRUGBANK:DB11058

subject_name: Petrolatum

object_name: seborrheic dermatitis


subject: CHEBI:119486

subject_name: Efavirenz

object_name: AIDS


subject: CHEBI:490877

subject_name: Didanosine


subject: UMLS:C1384659

object_name: Childhood Breast Carcinoma


subject: UMLS:C1384659

object_name: breast carcinoma


subject: UMLS:C1384659

object_name: breast cancer


subject: CHEBI:47426

subject_name: Furosemide

object_name: Breast cancer stage III


subject: CHEBI:47426

object_name: Breast cancer stage II


subject: CHEBI:47426

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:47426

object_name: malignant neoplasm of breast stage I


subject: CHEBI:47426

object_name: Carcinoma breast stage I


subject: CHEBI:47426

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:47426

object_name: Her2-receptor negative breast cancer


subject: CHEBI:47426

object_name: Musculoskeletal Pain


subject: CHEBI:47426

object_name: Adverse drug response


subject: CHEBI:36796

subject_name: duloxetine


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor

object_name: melanoma


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: severe hemophilia A


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Muscle Invasive Bladder Carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:94518

object_name: Osteoarthritis of ankle


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: peripheral vertigo


subject: CHEBI:6888

object_name: sudden hearing loss disorder


subject: CHEBI:6888

object_name: sudden sensorineural hearing loss


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: coronary microvascular disorder


subject: CHEBI:39548

object_name: Arrhythmia


subject: UNII:CW657OBU4N

subject_name: thyme extract

object_name: Fatty Liver


subject: UNII:CW657OBU4N

object_name: metabolic dysfunction-associated steatotic liver disease


subject: DRUGBANK:DB10983

subject_name: Thyme


subject: DRUGBANK:DB10983


subject: UNII:2UK410MY6B

subject_name: Thyme oil


subject: UNII:2UK410MY6B


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:41879

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: CHEBI:6888


subject: CHEBI:6888


subject: UNII:79R3ZF226Y

object_name: basal cell carcinoma


subject: UNII:79R3ZF226Y

object_name: skin basal cell carcinoma


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:60622


subject: CHEBI:60622


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: Pancreatic Cyst


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Unresectable Colorectal Carcinoma


subject: UNII:DPT0O3T46P

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C5666987

subject_name: Anti-CD79b Antibody-drug Conjugate SHR-A1912

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5666987

object_name: B-cell neoplasm


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:GN429E725A

object_name: Unresectable Malignant Solid Neoplasm


subject: UNII:GN429E725A

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:90199447

subject_name: TUVUSERTIB


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: T-Cell Lymphoma


subject: UNII:VRN8S9CW5V

subject_name: Nirsevimab

object_name: Recurrent lower respiratory tract infections


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: hypertrophic cardiomyopathy


subject: CHEBI:201431

object_name: Cardiomegaly


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:24743936

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:24743936

object_name: bipolar depression


subject: PUBCHEM.COMPOUND:24743936

object_name: bipolar II disorder


subject: PUBCHEM.COMPOUND:24743936

object_name: bipolar I disorder


subject: UMLS:C5707850

subject_name: Azetukalner


subject: UMLS:C5707850


subject: UMLS:C5707850


subject: UMLS:C5707850


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: Pneumonia caused by SARS-CoV-2


subject: PR:000006592


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: CHEBI:229213

subject_name: Elacestrant

object_name: Her2-receptor negative breast cancer


subject: CHEBI:7459

subject_name: Naloxone

object_name: Gambling


subject: UNII:N5UK68MGDZ

subject_name: Apremilast


subject: PUBCHEM.COMPOUND:70691420

subject_name: Aviptadil


subject: UNII:A67JUW790C

subject_name: aviptadil


subject: PUBCHEM.COMPOUND:6320532

subject_name: Cenicriviroc


subject: CHEBI:201431


subject: CHEBI:4031


subject: CHEBI:135041

subject_name: phenbenzamine


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEMBL.COMPOUND:CHEMBL2109330


subject: UMLS:C5417932

subject_name: IC 14


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEMBL.COMPOUND:CHEMBL4298195

subject_name: NARSOPLIMAB


subject: UMLS:C3896796

subject_name: narsoplimab


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Critical Illness


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C1328727

object_name: renal carcinoma


subject: UMLS:C1328727

object_name: kidney neoplasm


subject: UMLS:C1328727

object_name: kidney cancer


subject: UMLS:C1328727

object_name: skin melanoma


subject: CHEBI:57694

object_name: Atrophic oral lichen planus


subject: CHEBI:57694

object_name: Erosive oral lichen planus


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: UMLS:C4331211

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: sarcoidosis


subject: PUBCHEM.COMPOUND:6435378

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: type 1 diabetes mellitus


subject: CHEBI:80270


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177

object_name: type 2 diabetes mellitus


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UNII:G786V328X6

subject_name: Zatolmilast

object_name: fragile X syndrome


subject: CHEBI:131843

subject_name: Meldonium

object_name: Asthenia


subject: CHEBI:131843


subject: CHEBI:131843

object_name: Cognitive impairment


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: B-cell lymphoma refractory


subject: UNII:XRO4566Q4R

object_name: B-cell lymphoma recurrent


subject: UNII:XRO4566Q4R

object_name: Mantle cell lymphoma refractory


subject: UNII:XRO4566Q4R

object_name: Mantle cell lymphoma recurrent


subject: UNII:XRO4566Q4R

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UNII:XRO4566Q4R

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UMLS:C0594372

subject_name: Avonex


subject: UMLS:C0594372


subject: UMLS:C0594372


subject: UMLS:C0594372


subject: UMLS:C0594372


subject: UMLS:C0594372


subject: CHEBI:3901

subject_name: Tetracosactide

object_name: autosomal dominant polycystic kidney disease


subject: UMLS:C0383956

subject_name: HBOC 201

object_name: Anemia, severe


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: urgency urinary incontinence


subject: CHEBI:6121

subject_name: Ketamine

object_name: Hypoxemia


subject: CHEBI:6121

object_name: Blood oxygen concentration below reference range (finding)


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:94688

subject_name: Acipimox

object_name: hyperlipidemia


subject: CHEBI:94688

object_name: hyperlipoproteinemia


subject: CHEBI:94688

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:94688

object_name: Serum lipids high (finding)


subject: CHEBI:94688

object_name: HIV infection


subject: CHEBI:94688

object_name: Insulin resistance


subject: CHEBI:94688

object_name: hypertriglyceridemia


subject: CHEBI:94688

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:94688

object_name: cardiovascular disorder


subject: CHEBI:94688

object_name: heart disorder


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:63584

object_name: Childhood Breast Carcinoma


subject: CHEBI:63584

object_name: breast carcinoma


subject: CHEBI:63584

object_name: breast cancer


subject: CHEBI:63584

object_name: non-small cell lung carcinoma


subject: CHEBI:50858

subject_name: corticosteroid

object_name: melanoma


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: PUBCHEM.COMPOUND:4063

subject_name: Betalone


subject: CHEBI:135573

subject_name: Meprednisone


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UMLS:C5666845

subject_name: Aurora A Kinase Inhibitor VIC-1911

object_name: liver carcinoma


subject: UMLS:C2348411

object_name: Solid Neoplasm


subject: UMLS:C2348411

object_name: adult lymphoma


subject: UMLS:C2348411

object_name: lymphoma


subject: UMLS:C2348411

object_name: pediatric lymphoma


subject: CHEBI:231702

subject_name: Tirbanibulin


subject: CHEBI:231702


subject: CHEBI:231702


subject: CHEBI:231702


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:73272

object_name: Acute heart failure


subject: CHEBI:73272

object_name: heart failure


subject: CHEBI:73272

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:28793

object_name: Embolism, Tumor


subject: CHEBI:28793

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UMLS:C1541478

subject_name: Astuprotimut-R

object_name: skin melanoma


subject: UMLS:C1522481

subject_name: MART-1 Antigen


subject: UNII:3AU321J2HF

subject_name: SURVIVIN


subject: UMLS:C0664336

subject_name: survivin


subject: CHEBI:16526

subject_name: Carbon dioxide

object_name: Hypoventilation


subject: CHEBI:25805

subject_name: oxygen atom


subject: CHEBI:15379

subject_name: Oxygen


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: bronchiolitis obliterans syndrome


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PUBCHEM.COMPOUND:14228836

subject_name: Urate Oxidase

object_name: tumor lysis syndrome


subject: PUBCHEM.COMPOUND:14228836

object_name: Tumor Lysis Syndrome, CTCAE 3.0


subject: PUBCHEM.COMPOUND:14228836

object_name: Tumor Lysis Syndrome, CTCAE 5.0


subject: PR:000017226

subject_name: uricase


subject: PR:000017226


subject: PR:000017226


subject: UMLS:C0041931

subject_name: URATE OXIDASE


subject: UMLS:C0041931


subject: UMLS:C0041931


subject: GTOPDB:5015

subject_name: leptin

object_name: Cushing syndrome


subject: GTOPDB:5015

object_name: adrenal gland hyperfunction


subject: CHEBI:81571

subject_name: Leptin


subject: CHEBI:81571


subject: UMLS:C3535635

subject_name: leptin human


subject: UMLS:C3535635


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Blood Pressure Finding


subject: CHEBI:66964

object_name: Systemic arterial pressure


subject: CHEBI:158723

subject_name: Arg-Arg-Arg

object_name: arteriosclerosis disorder


subject: CHEBI:158723

object_name: atherosclerosis


subject: CHEBI:53534

subject_name: poly(L-arginine) macromolecule


subject: CHEBI:53534


subject: CHEBI:61492

subject_name: poly(L-arginine) polymer


subject: CHEBI:61492


subject: UMLS:C0071514

subject_name: polyarginine


subject: UMLS:C0071514


subject: CHEBI:10033

subject_name: Warfarin

object_name: Blood Clot


subject: CHEBI:10033

object_name: thrombosis


subject: CHEBI:10033

object_name: Thrombosis of blood vessel


subject: CHEBI:18361


subject: CHEBI:18361


subject: CHEBI:18361


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:53266


subject: CHEBI:53266


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:35782


subject: CHEBI:35782


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:60614


subject: CHEBI:60614


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: CHEBI:29888


subject: CHEBI:29888


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: CHEBI:8988

object_name: leukemia


subject: CHEBI:8988

object_name: childhood leukemia


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:31905

subject_name: Nicorandil


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:27958

subject_name: Cocaine

object_name: Cocaine adverse reaction


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: type 2 diabetes mellitus


subject: UMLS:C4287766

object_name: gastric adenocarcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:184381

subject_name: Bacitracin

object_name: paranasal sinus disorder


subject: UMLS:C4329512

subject_name: UCPVax

object_name: liver carcinoma


subject: UMLS:C0281722

subject_name: gp100 Antigen

object_name: skin melanoma


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: UMLS:C0677989

subject_name: Tetanus Peptide Melanoma Vaccine


subject: UMLS:C0338254

subject_name: tyrosinase peptide


subject: MESH:C086631

subject_name: mineral trioxide aggregate

object_name: Dentin bridge


subject: CHEBI:23359

subject_name: colchicine

object_name: chronic kidney disease


subject: CHEBI:23359

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C5418044

object_name: Solid Neoplasm


subject: UMLS:C4688441

subject_name: Promenakin

object_name: Pneumonia caused by SARS-CoV-2


subject: UNII:67RM91WDHQ

subject_name: Onvansertib

object_name: pancreatic ductal adenocarcinoma


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: plasma cell myeloma


subject: UNII:F40IRN5981

subject_name: Chiauranib


subject: UMLS:C3896796

subject_name: narsoplimab

object_name: IgA Nephropathy


subject: CHEBI:6759

subject_name: Mepivacaine

object_name: Compartment syndrome of lower limb due to traumatic injury


subject: UMLS:C3273554

object_name: glioblastoma


subject: UMLS:C3273554

object_name: Childhood Glioblastoma


subject: UMLS:C3273554

object_name: adult glioblastoma


subject: UMLS:C3273554

object_name: MGMT-Unmethylated Glioblastoma


subject: UMLS:C1328728

object_name: malignant soft tissue neoplasm


subject: UMLS:C1328728

object_name: sarcoma


subject: CHEBI:32682

subject_name: L-argininium

object_name: preeclampsia


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:229764

subject_name: Selinexor

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: gestational trophoblastic neoplasm


subject: CHEBI:63611

object_name: testicular germ cell tumor 1


subject: CHEBI:63611

object_name: testicular germ cell tumor


subject: CHEBI:63611

object_name: childhood testicular germ cell tumor


subject: CHEBI:63611


subject: CHEBI:63611

object_name: myeloproliferative neoplasm


subject: CHEBI:63611

object_name: Myelodysplasia


subject: CHEBI:63611

object_name: Childhood Breast Carcinoma


subject: CHEBI:63611

object_name: breast carcinoma


subject: CHEBI:63611

object_name: breast cancer


subject: CHEBI:63611

object_name: ovarian cancer


subject: CHEBI:63611

object_name: ovarian neoplasm


subject: CHEBI:63611

object_name: ovarian carcinoma


subject: CHEBI:63611

object_name: Childhood Neuroblastoma


subject: CHEBI:63611

object_name: neuroblastoma


subject: CHEBI:63611

object_name: adult lymphoma


subject: CHEBI:63611

object_name: lymphoma


subject: CHEBI:63611

object_name: pediatric lymphoma


subject: CHEBI:63611

object_name: leukemia


subject: CHEBI:63611

object_name: childhood leukemia


subject: CHEBI:6931

subject_name: Midazolam

object_name: chronic back pain


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: colorectal neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C5706409

subject_name: Anti-EGFR/c-MET/c-MET Trispecific Antibody GB263T

object_name: non-small cell lung carcinoma


subject: CHEBI:31485

subject_name: Difluprednate

object_name: uveitis


subject: CHEBI:31485

object_name: Uveitis, CTCAE


subject: CHEBI:31485

object_name: Macular Edema


subject: CHEBI:75922

subject_name: Nepafenac


subject: CHEBI:75922


subject: CHEBI:75922


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte


subject: PUBCHEM.COMPOUND:4895


subject: PUBCHEM.COMPOUND:4895


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: UMLS:C4530095

subject_name: varicella zoster virus glycoprotein E, recombinant

object_name: herpes zoster


subject: UNII:FBK9G669EY

subject_name: CHO CELL


subject: CHEBI:2469

subject_name: Adefovir


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: HIV infection


subject: UMLS:C0021741

subject_name: Actimmune


subject: CHEBI:32599

object_name: bronchiolitis


subject: CHEBI:32599

object_name: abnormal; blood level, magnesium


subject: CHEBI:37409

subject_name: crown compound

object_name: Crohn disease


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Severe Sepsis


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:39501

subject_name: trientine

object_name: Wilson disease


subject: UMLS:C1321997

subject_name: sodium chloride 3 %


subject: UMLS:C1321997

object_name: Wheezing


subject: UMLS:C1321997

object_name: Wheezing, CTCAE


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: severe combined immunodeficiency


subject: UMLS:C5239502

subject_name: Salovum

object_name: traumatic encephalopathy


subject: UMLS:C5239502

object_name: traumatic brain injury


subject: CHEBI:94366

subject_name: itraconazole

object_name: prostate carcinoma


subject: CHEBI:94366

object_name: prostate cancer


subject: CHEBI:94366

object_name: metastatic prostate carcinoma


subject: CHEBI:94366

object_name: prostate adenocarcinoma


subject: UNII:P76B05O5V6

subject_name: Relugolix


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0770246

object_name: obesity


subject: UMLS:C0770246

object_name: Obesity, CTCAE


subject: UNII:K9TZK4MNO6

subject_name: Halofenate

object_name: Hyperuricemia


subject: UNII:K9TZK4MNO6

object_name: Hyperuricemia, CTCAE


subject: UNII:K9TZK4MNO6

object_name: gout


subject: UNII:1P01UJR9X1

subject_name: Arhalofenate


subject: UNII:1P01UJR9X1


subject: UNII:1P01UJR9X1


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:23359


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: thyroid gland squamous cell carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:75998

subject_name: Trametinib


subject: UMLS:C1170183

subject_name: Copegus

object_name: chronic hepatitis C virus infection


subject: UNII:TA63JX8X52

subject_name: Mericitabine


subject: UMLS:C0305062

subject_name: Tetanus Toxoid

object_name: bladder tumor


subject: UMLS:C0305062

object_name: urinary bladder carcinoma


subject: UMLS:C0305062

object_name: urinary bladder cancer


subject: UMLS:C0305062

object_name: childhood bladder carcinoma


subject: UMLS:C0305062

object_name: Childhood Breast Carcinoma


subject: UMLS:C0305062

object_name: breast carcinoma


subject: UMLS:C0305062

object_name: breast cancer


subject: UMLS:C0305062

object_name: colon carcinoma


subject: UMLS:C0305062

object_name: colorectal cancer


subject: UMLS:C0305062

object_name: colon cancer


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C5240013

subject_name: Vaccine product containing only Clostridium tetani antigen (medicinal product)


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C0021761


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: DRUGBANK:DB10989

subject_name: Hepatitis A Vaccine


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: DRUGBANK:DB10989


subject: UMLS:C0170300

subject_name: Hepatitis A Vaccines


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: UMLS:C0170300


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: PUBCHEM.COMPOUND:16131310


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: DRUGBANK:DB11627


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: UMLS:C0062527


subject: MESH:D022242

subject_name: Pneumococcal Vaccines


subject: MESH:D022242


subject: MESH:D022242


subject: MESH:D022242


subject: MESH:D022242


subject: MESH:D022242


subject: MESH:D022242


subject: MESH:D022242


subject: MESH:D022242


subject: MESH:D022242


subject: UMLS:C5240157

subject_name: Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: UMLS:C5240157


subject: CHEBI:93109

subject_name: Semaxanib

object_name: Renal cell carcinoma recurrent


subject: CHEBI:93109

object_name: Renal cancer recurrent


subject: CHEBI:93109

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:93109

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:93109

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab

object_name: Hot Flashes, CTCAE


subject: PUBCHEM.COMPOUND:45357473

object_name: Hot flashes


subject: UMLS:C5854619

subject_name: Oncolytic VSV-GP BI 1821736

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: bacterial vaginosis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: rotator cuff syndrome


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE

object_name: sickle cell disease


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab


subject: UMLS:C0665297

subject_name: natalizumab


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Inflammation


subject: UMLS:C5439905


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: UMLS:C1174783

subject_name: Zarnestra


subject: UMLS:C0393031


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: Subdural hemorrhage


subject: UMLS:C0074926

subject_name: Soy Proteins

object_name: Osteopenia


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:95021

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:95021

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:95021

object_name: soft tissue sarcoma


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: MESH:D004573

subject_name: Electrolytes

object_name: Control of hip fracture risk


subject: MESH:D004573

object_name: hip fracture


subject: UMLS:C3536863

subject_name: Electrolyte [EPC]


subject: UMLS:C3536863


subject: CHEBI:3125

subject_name: Bisacodyl


subject: CHEBI:3125


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:30742


subject: PUBCHEM.COMPOUND:10065020

subject_name: Traxoprodil

object_name: major depressive disorder


subject: DRUGBANK:DB18795


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Ankle Sprains


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: bipolar disorder


subject: CHEBI:43830

subject_name: Methylthioninium


subject: UNII:D0VK52NV5M

subject_name: Asimadoline

object_name: Postoperative ileus


subject: CHEBI:133641

subject_name: Ile-Gly

object_name: Viremia


subject: CHEBI:133641

object_name: Viremia, CTCAE


subject: UMLS:C0360506

subject_name: intramuscular immunoglobulin


subject: UMLS:C0360506


subject: UMLS:C0305052

subject_name: Gamma globulin serum


subject: UMLS:C0305052


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: UMLS:C0021027


subject: UMLS:C1831593

subject_name: Denenicokin

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C1831593

object_name: non-Hodgkin lymphoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: shoulder impingement syndrome


subject: CHEBI:6129

object_name: Coracohumeral Impingement Syndrome


subject: PUBCHEM.COMPOUND:49800030

subject_name: METHYLPREDNISOLONE ACETATE


subject: PUBCHEM.COMPOUND:49800030


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: PUBCHEM.COMPOUND:584547


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: pure red-cell aplasia


subject: UNII:4F4X42SYQ6

object_name: Diamond-Blackfan anemia


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:229469

subject_name: Sulodexide

object_name: diabetic kidney disease


subject: CHEBI:8863

subject_name: Riluzole

object_name: Childhood Breast Carcinoma


subject: CHEBI:8863

object_name: breast carcinoma


subject: CHEBI:8863

object_name: breast cancer


subject: CHEBI:31705

subject_name: Iodixanol

object_name: acute myocardial infarction


subject: CHEBI:31705

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:31705

object_name: contrast-induced nephropathy


subject: CHEBI:63578

subject_name: Iopromide


subject: CHEBI:63578


subject: CHEBI:63578


subject: MESH:C464842

subject_name: Canvaxin

object_name: melanoma


subject: CHEMBL.COMPOUND:CHEMBL2108126

subject_name: PSYLLIUM HUSK

object_name: abdominal obesity-metabolic syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108126

object_name: Schizophrenia, Disorganized


subject: CHEMBL.COMPOUND:CHEMBL2108126

object_name: Overweight and obesity


subject: DRUGBANK:DB11097

subject_name: Plantago seed


subject: DRUGBANK:DB11097


subject: DRUGBANK:DB11097


subject: CHEBI:165446

subject_name: Psyllic acid


subject: CHEBI:165446


subject: UNII:64FS3BFH5W

subject_name: EPOETIN

object_name: Renal anaemia


subject: UNII:64FS3BFH5W

object_name: end stage renal failure


subject: UNII:64FS3BFH5W

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: UMLS:C0014822

subject_name: Erythropoietin


subject: UMLS:C0014822


subject: UMLS:C0014822


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: oral submucous fibrosis


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UMLS:C1517701

subject_name: labetuzumab

object_name: colorectal neoplasm


subject: GTOPDB:8251


subject: UNII:EFE6X5M3UY


subject: GTOPDB:13790

subject_name: benmelstobart

object_name: biliary tract neoplasm


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: CHEBI:31347

subject_name: camostat mesylate

object_name: severe acute respiratory syndrome


subject: CHEBI:135632

subject_name: Camostat


subject: UMLS:C0108225

subject_name: Camostat mesylate


subject: UMLS:C0028569

subject_name: Nubain

object_name: sickle cell disease


subject: CHEBI:7454

subject_name: Nalbuphine


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Childhood Breast Carcinoma


subject: UNII:8M7YSN2KII

object_name: breast carcinoma


subject: UNII:8M7YSN2KII

object_name: breast cancer


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: CHEBI:7454

object_name: Post-Operative Pain


subject: UNII:DRP53ZDY6H


subject: UMLS:C5690696

subject_name: MitoQ

object_name: Cognitive impairment


subject: UMLS:C5690696

object_name: Mitochondrial alteration


subject: UMLS:C5690696

object_name: Schizophrenia and related disorders


subject: CHEBI:3219

subject_name: Bupropion

object_name: bipolar disorder


subject: UMLS:C3641657

subject_name: CEND 1

object_name: colon carcinoma


subject: UMLS:C3641657

object_name: colon cancer


subject: UMLS:C3641657

object_name: pancreatic neoplasm


subject: UMLS:C3641657

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3641657

object_name: malignant pancreatic neoplasm


subject: UMLS:C3641657

object_name: digestive system cancer


subject: MESH:C000627770

subject_name: folfirinox


subject: MESH:C000627770


subject: MESH:C000627770


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UMLS:C4329336

object_name: neoplasm


subject: DRUGBANK:DB14744

subject_name: Spirulina platensis

object_name: cholangiocarcinoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Multi vessel coronary artery disease


subject: CHEBI:82339

subject_name: Merphalan

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W

object_name: non-Hodgkin lymphoma


subject: UNII:D7RD81HE4W

object_name: Hodgkin Disease


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:165821

subject_name: CpA

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:165821

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C3273718

subject_name: Maveropepimut-S


subject: UMLS:C3273718


subject: UMLS:C5206815

object_name: cancer


subject: CHEBI:66903

subject_name: Vismodegib

object_name: basal cell carcinoma


subject: CHEBI:66903

object_name: Disorder due to radiotherapy


subject: PUBCHEM.COMPOUND:2877953

object_name: plasma cell myeloma


subject: CHEBI:32696

object_name: sickle cell disease


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Ambulatory Status - Mastectomy


subject: CHEBI:35475

object_name: Post-Operative Pain


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: UMLS:C0242402

subject_name: Opioids


subject: UMLS:C0242402


subject: CHEBI:83766

subject_name: Olaparib

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Premature birth


subject: UNII:NM2KXJ990T

subject_name: Nebicapone

object_name: Parkinson disease


subject: UMLS:C3489562


subject: UMLS:C0876119

subject_name: Paxil CR

object_name: Depressed mood


subject: CHEBI:4887

subject_name: Ethosuximide

object_name: epilepsy


subject: CHEBI:4887

object_name: childhood absence epilepsy


subject: CHEBI:4887

object_name: Seizure Related to COVID-19


subject: CHEBI:4887

object_name: visual epilepsy


subject: CHEBI:6367

subject_name: Lamotrigine


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:139072

object_name: Stress


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:49668

subject_name: Gefitinib

object_name: renal carcinoma


subject: CHEBI:49668

object_name: kidney neoplasm


subject: CHEBI:49668

object_name: kidney cancer


subject: CHEBI:31608

subject_name: ferrous gluconate

object_name: endometrial cancer


subject: CHEBI:31608

object_name: uterine corpus cancer


subject: CHEBI:31608

object_name: endometrial carcinoma


subject: CHEBI:31608

object_name: Perioperative complication


subject: UNII:AIS8N3O50B

subject_name: Seltorexant

object_name: insomnia


subject: UMLS:C5139948


subject: CHEBI:91327

subject_name: Tivozanib

object_name: colorectal cancer


subject: CHEBI:91327

object_name: colorectal carcinoma


subject: CHEBI:91327

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1289970

subject_name: intravesical bcg

object_name: bladder tumor


subject: UMLS:C1289970

object_name: urinary bladder carcinoma


subject: UMLS:C1289970

object_name: urinary bladder cancer


subject: UMLS:C1289970

object_name: childhood bladder carcinoma


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Chronic Insomnia


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PR:000017019

object_name: Pancreatic carcinoma stage III


subject: PR:000017019

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: GTOPDB:7984

subject_name: edrecolomab


subject: GTOPDB:7984


subject: GTOPDB:7984


subject: CHEMBL.COMPOUND:CHEMBL2108955

subject_name: EDRECOLOMAB


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: CHEBI:15365

subject_name: Aspirin

object_name: Maternal hypertension


subject: CHEBI:15365

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:15365

object_name: obesity


subject: CHEBI:15365

object_name: Obesity, CTCAE


subject: UMLS:C4757708

subject_name: Telmisartan only product in oral dose form

object_name: panic disorder


subject: UMLS:C4757708

object_name: panic disorder 1


subject: UMLS:C4757708

object_name: mental disorder


subject: UMLS:C4757708

object_name: psychiatric disorder


subject: UMLS:C4757708

object_name: History of - psychiatric disorder


subject: UMLS:C4757886

subject_name: Verapamil only product in oral dose form


subject: UMLS:C4757886


subject: UMLS:C4757886


subject: UMLS:C4757886


subject: UMLS:C4757886


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: complete trisomy 21


subject: UMLS:C0085297

object_name: Down syndrome


subject: UMLS:C0085297

object_name: Regression


subject: UMLS:C0085297

object_name: Tumor Regression


subject: UMLS:C0085297

object_name: Developmental regression


subject: CHEBI:52993

subject_name: Lormetazepam


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: CHEBI:71200


subject: CHEBI:71200


subject: CHEBI:71200


subject: UMLS:C3489797

object_name: type 2 diabetes mellitus


subject: UMLS:C3489797

object_name: Insulin resistance


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:17650

object_name: acute stress disorder


subject: CHEBI:84415

subject_name: acetyltaurine

object_name: X-linked Opitz G/BBB syndrome


subject: CHEBI:84415

object_name: genetic developmental and epileptic encephalopathy


subject: CHEBI:84415

object_name: Opening Snap


subject: CHEBI:84415

object_name: outcomes general quality of life


subject: CHEBI:84415

object_name: Perceived quality of life


subject: CHEBI:84415

object_name: Good quality of life


subject: PR:000014937

subject_name: Na(+)/citrate cotransporter


subject: PR:000014937


subject: PR:000014937


subject: PR:000014937


subject: PR:000014937


subject: PR:000014937


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: neonatal sepsis


subject: UMLS:C1440867

object_name: Bacterial sepsis of newborn


subject: UMLS:C1440867

object_name: perinatal necrotizing enterocolitis


subject: UMLS:C1440867

object_name: necrotizing enterocolitis


subject: UMLS:C1440867

object_name: Necrotizing Enterocolitis, AE


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: Heart Disease Risk Factors


subject: CHEBI:28793

object_name: Inflammation


subject: CHEBI:28793

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:28793

object_name: metabolic syndrome X


subject: CHEBI:28793

object_name: Dyslipidemia


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: CHEBI:24151

subject_name: galactooligosaccharide


subject: CHEBI:24151


subject: CHEBI:24151


subject: CHEBI:24151


subject: CHEBI:24151


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin


subject: PUBCHEM.COMPOUND:18772499


subject: PUBCHEM.COMPOUND:18772499


subject: PUBCHEM.COMPOUND:18772499


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: CHEBI:143528

subject_name: DL-Arabinose


subject: CHEBI:143528


subject: CHEBI:143528


subject: CHEBI:143528


subject: CHEBI:143528


subject: UNII:89NA02M4RX

subject_name: PECTIN


subject: UNII:89NA02M4RX


subject: UNII:89NA02M4RX


subject: UNII:89NA02M4RX


subject: UNII:89NA02M4RX


subject: CHEBI:17309

subject_name: pectin


subject: CHEBI:17309


subject: CHEBI:17309


subject: CHEBI:17309


subject: CHEBI:17309


subject: CHEBI:94531

subject_name: belinostat

object_name: intraocular lymphoma


subject: CHEBI:94531

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:94531

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:94531

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:94531

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:94531

object_name: anaplastic large cell lymphoma


subject: CHEBI:94531

object_name: Mantle cell lymphoma stage III


subject: CHEBI:94531

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:94531

object_name: small intestine lymphoma


subject: CHEBI:94531

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:94531

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:94531

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:94531

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:94531

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:94531

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:94531

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:94531

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:94531

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:94531

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:94531

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:94531

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:94531

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:94531

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:94531

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:94531

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:94531

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:94531

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:94531

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:94531

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:94531

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:94531

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:94531

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:94531

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:94531

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:94531

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:94531

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:94531

object_name: splenic marginal zone lymphoma


subject: CHEBI:94531

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:94531

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:94531

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:94531

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:94531

object_name: MALT lymphoma


subject: CHEBI:94531

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:94531

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Marginal zone lymphoma stage III


subject: CHEBI:94531

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:94531

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:94531

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:94531

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:94531

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:94531

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:94531

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:94531

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:94531


subject: CHEBI:94531

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:94531

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:94531

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: intraocular lymphoma


subject: CHEBI:64153


subject: CHEBI:64153


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:7421

subject_name: NAC

object_name: pulmonary fibrosis


subject: CHEBI:7421

object_name: Pulmonary Fibrosis, CTCAE


subject: PUBCHEM.COMPOUND:66720278

subject_name: Cadazolid

object_name: Clostridium difficile colitis


subject: PUBCHEM.COMPOUND:66720278

object_name: clostridium difficile infection


subject: UMLS:C2001816

subject_name: Aluvia

object_name: HIV infection


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Primary focal hyperhidrosis of axilla


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: body weight


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Androgen excess


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: chronic disease


subject: UMLS:C0003442

object_name: Chronic Disease


subject: UMLS:C0003442

object_name: Myelodysplasia, CTCAE


subject: UMLS:C0003442

object_name: acute leukemia


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: diabetes mellitus


subject: CHEBI:49960

subject_name: Vandetanib

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:49960

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:79V7Q9VIWQ

subject_name: NOMACOPAN

object_name: thrombotic microangiopathy


subject: UMLS:C5139797

subject_name: Nomacopan


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Stent thrombosis


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4724025

subject_name: babaodan capsule

object_name: radiation pneumonitis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: diabetic kidney disease


subject: CHEBI:9241

object_name: diabetic retinopathy


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Rheumatism


subject: UMLS:C0378942


subject: UMLS:C5783900

subject_name: BCR-ABL Inhibitor ELVN-001

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C5783900

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:63631

subject_name: Topiramate

object_name: generalized epilepsy


subject: CHEBI:63631

object_name: Bilateral tonic-clonic seizure


subject: PUBCHEM.COMPOUND:123315041

subject_name: VIBEGRON

object_name: Neurogenic detrusor overactivity


subject: UNII:YO029HR229

object_name: prostate carcinoma


subject: UNII:YO029HR229

object_name: prostate cancer


subject: UNII:YO029HR229

object_name: prostate neoplasm


subject: UMLS:C3530086


subject: UMLS:C3530086


subject: UMLS:C3530086


subject: CHEBI:63610

subject_name: Misoprostol

object_name: submucous uterine fibroid


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: PUBCHEM.COMPOUND:9886134

subject_name: Branched chain amino acids

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:9886134

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:9886134

object_name: sleep disorder


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain


subject: UMLS:C0002521


subject: UMLS:C0002521


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Barrett esophagus


subject: UMLS:C2830125

object_name: Hepatic impairment


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: psoriasis vulgaris


subject: UMLS:C0358976

subject_name: Dermovate cream


subject: UMLS:C3530593

subject_name: Synalar Ointment


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: acne


subject: CHEBI:50815

subject_name: Norgestimate


subject: CHEBI:5390

subject_name: Glu-Glu


subject: CHEBI:2704

subject_name: Anastrozole

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:2704

object_name: obesity


subject: CHEBI:2704

object_name: Obesity, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Birthing Labor


subject: CHEBI:6149

subject_name: Levobupivacaine


subject: PUBCHEM.COMPOUND:10207484

subject_name: Custodiol

object_name: coronary stenosis


subject: CHEBI:17347

subject_name: Testosterone

object_name: Low-Calorie Diet


subject: UNII:TG8IQ19NG2

subject_name: Ansuvimab

object_name: Ebola hemorrhagic fever


subject: PR:000005931

object_name: Primary bacterial peritonitis


subject: PR:000005931

object_name: acute spontaneous bacterial peritonitis


subject: CHEBI:31401

subject_name: Cilostazol

object_name: intermittent vascular claudication


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: metastatic malignant neoplasm in the brain


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Recurrent Malignant Brain Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Childhood Brain Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: brain cancer


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: brain neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: pediatric lymphoma


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: CHEBI:68841

subject_name: Gadobutrol


subject: CHEBI:68841


subject: CHEBI:68841


subject: CHEBI:68841


subject: CHEBI:68841


subject: CHEBI:68841


subject: CHEBI:68841


subject: CHEBI:68841


subject: CHEBI:1989

subject_name: Modufolin

object_name: Colon Neoplasm


subject: UMLS:C4760869


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: PUBCHEM.COMPOUND:139600705

subject_name: Pramlintide

object_name: skin squamous cell carcinoma


subject: PUBCHEM.COMPOUND:139600705

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:66964

object_name: Back pain


subject: CHEBI:66964

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:66964

object_name: Neck pain


subject: CHEBI:66964

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:66964

object_name: Neck Pain, CTCAE 3.0


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: UMLS:C4284724

subject_name: Allele-Specific Oligonucleotide

object_name: genetic disease


subject: UMLS:C0003436

subject_name: Antistreptolysin O


subject: CHEBI:82699

subject_name: Oritavancin

object_name: Acute bacterial skin and skin structure infection


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Chronic nontraumatic dissection of thoracic aorta


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:231679

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Progressive cGVHD


subject: UNII:MRL3739G66

object_name: Progressive Disease


subject: UNII:MRL3739G66

object_name: Progressive Neoplastic Disease


subject: UNII:MRL3739G66

object_name: IMWG Progressive Disease


subject: UNII:MRL3739G66

object_name: irPD (Immune-Related Response Criteria)


subject: UNII:MRL3739G66

object_name: Global Progressive Disease in Viscera


subject: UNII:MRL3739G66

object_name: RECIL PD


subject: UNII:MRL3739G66

object_name: Global Progressive Disease in Skin


subject: UNII:MRL3739G66

object_name: Global Progressive Disease


subject: UNII:MRL3739G66

object_name: Global Progressive Disease in Lymph Nodes


subject: UNII:MRL3739G66

object_name: Global Progressive Disease in Blood


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: kidney benign neoplasm


subject: UMLS:C3898831

object_name: renal cell adenocarcinoma


subject: UMLS:C3898831

object_name: kidney cancer


subject: UMLS:C3898831

object_name: renal cell carcinoma


subject: UMLS:C3898831

object_name: childhood kidney cell carcinoma


subject: UMLS:C3898831

object_name: kidney neoplasm


subject: UMLS:C3898831

object_name: childhood kidney neoplasm


subject: CHEBI:4466

object_name: Parkinson disease


subject: UNII:7N8K34P2XH


subject: UMLS:C5417830

subject_name: Rilunermin Alfa

object_name: peritoneal carcinomatosis


subject: CHEBI:6801

subject_name: Metformin

object_name: melanoma


subject: CHEBI:6801

object_name: Microsatellite instability-high solid malignant tumor


subject: CHEBI:188074

object_name: non-small cell lung carcinoma


subject: CHEBI:188074


subject: CHEBI:188074

object_name: head and neck squamous cell carcinoma


subject: CHEBI:188074

object_name: gastric adenocarcinoma


subject: CHEBI:188074

object_name: esophageal adenocarcinoma


subject: CHEBI:188074


subject: CHEBI:188074

object_name: liver carcinoma


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:29191

subject_name: hydroxyl

object_name: vitamin D deficiency


subject: CHEBI:29191

object_name: rickets


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: UMLS:C0700307


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: CHEBI:16234


subject: CHEBI:31593

subject_name: fasudil hydrochloride

object_name: ovarian cancer


subject: CHEBI:31593

object_name: ovarian neoplasm


subject: CHEBI:31593

object_name: ovarian carcinoma


subject: CHEBI:43871

subject_name: Fasudil


subject: CHEBI:43871


subject: CHEBI:43871


subject: UMLS:C0526099


subject: UMLS:C0526099


subject: UMLS:C0526099


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: Rheumatism


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: asthma


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: UMLS:C1622916

subject_name: ISOPROPYL ALCOHOL 70%

object_name: bacteriemia


subject: UMLS:C1622916

object_name: Bacteremia, CTCAE


subject: CHEBI:17824

subject_name: isopropanol


subject: CHEBI:17824


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: obstructive sleep apnea syndrome


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:167309

subject_name: Methadone

object_name: head and neck cancer


subject: CHEBI:8452

subject_name: Proflavine

object_name: cervical carcinoma


subject: CHEBI:4530

subject_name: Diethylpropion

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4530

object_name: obesity


subject: CHEBI:4530

object_name: Obesity, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu

object_name: skin basal cell carcinoma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: osteoarthritis


subject: UNII:CVX52RV2DC

subject_name: TELISOTUZUMAB ADIZUTECAN

object_name: colorectal cancer


subject: UNII:CVX52RV2DC

object_name: colorectal carcinoma


subject: UNII:CVX52RV2DC

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Sleep Deprivation


subject: PUBCHEM.COMPOUND:3021749

object_name: status asthmaticus


subject: PUBCHEM.COMPOUND:3021749

object_name: Acute severe refractory exacerbation of asthma


subject: UNII:GR88G0I6UL

subject_name: IPRATROPIUM


subject: UNII:GR88G0I6UL


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:657309


subject: UNII:Q1418F39MH

subject_name: TAC 101

object_name: liver carcinoma


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: complications; penile prosthesis, infection or inflammation


subject: CHEBI:3614

object_name: impotence


subject: CHEBI:3614

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:3614

object_name: Erectile dysfunction


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: third-degree atrioventricular block


subject: CHEBI:41879

object_name: second-degree atrioventricular block


subject: CHEBI:33838

subject_name: nucleoside

object_name: HIV infection


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: pancreatic adenosquamous carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: pancreatic acinar cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: squamous cell carcinoma of pancreas


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: colorectal neoplasm


subject: CHEBI:74705

object_name: hypokalemia


subject: CHEBI:74705

object_name: Hypokalemia, CTCAE


subject: CHEBI:74705

object_name: dehydration (Na, H2O)


subject: CHEBI:74705

object_name: Dehydration, CTCAE


subject: CHEBI:74705

object_name: Dehydration


subject: CHEBI:74705

object_name: Hyponatremia


subject: CHEBI:74705

object_name: Hyponatremia, CTCAE


subject: CHEBI:74705

object_name: Hypernatremia


subject: CHEBI:74705

object_name: Hypernatremia, CTCAE


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:5801

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:85993

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: anus cancer


subject: UNII:28X28X9OKV

object_name: anal carcinoma


subject: UNII:28X28X9OKV

object_name: anal margin carcinoma


subject: UNII:28X28X9OKV

object_name: Anal cancer stage II


subject: UNII:28X28X9OKV

object_name: Anal cancer stage III


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:26195

subject_name: polyphenol

object_name: Inflammatory disorder of the cardiovascular system


subject: UNII:FM5526K07A

subject_name: ZINC ACETATE

object_name: cystic fibrosis


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: chronic hepatitis D infection


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:61599

object_name: prostate carcinoma


subject: CHEBI:61599

object_name: prostate cancer


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]

object_name: atrial fibrillation


subject: UMLS:C3536711

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C3536711

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Uremic pruritus


subject: CHEBI:4911

subject_name: Etoposide

object_name: pancreatic neoplasm


subject: CHEBI:4911

object_name: exocrine pancreatic carcinoma


subject: CHEBI:4911

object_name: malignant pancreatic neoplasm


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: mild neurocognitive disorder


subject: UMLS:C0037668

object_name: mild cognitive impairment


subject: UNII:4UR7N9Z9MM

subject_name: Somatorelin


subject: UNII:4UR7N9Z9MM


subject: GTOPDB:3602

subject_name: GHRH


subject: GTOPDB:3602


subject: CHEBI:83766

subject_name: Olaparib

object_name: Neoplasm of uncertain or unknown behavior of prostate


subject: CHEBI:83766

object_name: grade III prostatic intraepithelial neoplasia


subject: CHEBI:83766

object_name: benign neoplasm of prostate


subject: CHEBI:6931

subject_name: Midazolam

object_name: myositis ossificans


subject: CHEBI:6931

object_name: fibrodysplasia ossificans progressiva


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: colorectal cancer


subject: CHEBI:49900

object_name: colorectal carcinoma


subject: CHEBI:49900

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Metastatic gastric adenocarcinoma


subject: UMLS:C4287766

object_name: esophageal adenocarcinoma


subject: UMLS:C4287766


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: PUBCHEM.COMPOUND:160283094

subject_name: ZONGERTINIB

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:160283094


subject: PUBCHEM.COMPOUND:160283094


subject: PUBCHEM.COMPOUND:160283094


subject: UNII:DRH7R67UVL


subject: UNII:DRH7R67UVL


subject: UNII:DRH7R67UVL


subject: UNII:DRH7R67UVL


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: endometrial carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:195556

object_name: Solid Neoplasm


subject: CHEBI:195556


subject: CHEBI:195556


subject: CHEBI:195556


subject: CHEBI:195556

object_name: ovarian cancer


subject: CHEBI:195556

object_name: ovarian neoplasm


subject: CHEBI:195556

object_name: ovarian carcinoma


subject: UMLS:C4760874


subject: UMLS:C4760874


subject: UMLS:C4760874


subject: UMLS:C4760874


subject: UMLS:C4760874


subject: UMLS:C4760874


subject: UMLS:C4760874


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C5432262

subject_name: zansecimab

object_name: pneumonia


subject: UMLS:C5432262

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C5432262


subject: CHEBI:10125

subject_name: Zolpidem

object_name: performance enhancing product use


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant


subject: CHEBI:90942

subject_name: Ixazomib

object_name: acute myeloid leukemia


subject: CHEBI:90942

object_name: adult acute myeloid leukemia


subject: UNII:6ZJ8V3Q0H1


subject: UMLS:C5553010

subject_name: Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody/CD40L/4-1BBL RP3

object_name: Advanced Malignant Solid Neoplasm


subject: PR:000014181

subject_name: X-linked retinitis pigmentosa GTPase regulator


subject: PR:000010172

subject_name: microtubule-associated protein RP/EB family member 3


subject: DRUGBANK:DB18525

object_name: wild type ATTR amyloidosis


subject: DRUGBANK:DB18525

object_name: Cardiac amyloidosis


subject: DRUGBANK:DB18525

object_name: Transthyretin-related (ATTR) familial amyloid cardiomyopathy


subject: DRUGBANK:DB18525

object_name: Transthyretin-related (ATTR) familial amyloid polyneuropathy


subject: CHEBI:91899

object_name: Rhinosinusitis


subject: CHEBI:91899

object_name: POLYPOSIS CHRONIC


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: UNII:S866O45PIG

subject_name: Beractant

object_name: Perinatal pulmonary hemorrhage


subject: UNII:S866O45PIG

object_name: Pulmonary hemorrhage


subject: UNII:KE3U2023NP

subject_name: Poractant alfa


subject: UNII:KE3U2023NP


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: vital signs


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:155761

subject_name: Tricosanal

object_name: leukemia


subject: PUBCHEM.COMPOUND:155761

object_name: childhood leukemia


subject: UNII:DJJ95FJP1H

subject_name: Choline magnesium trisalicylate


subject: UNII:DJJ95FJP1H


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: hypogonadism, male


subject: GTOPDB:11592

subject_name: evorpacept

object_name: Stomach cancer


subject: GTOPDB:11592

object_name: gastric cancer


subject: GTOPDB:11592


subject: GTOPDB:11592

object_name: gastric adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: CHEBI:7889

subject_name: Peoniflorin

object_name: autoimmune hepatitis


subject: PUBCHEM.COMPOUND:46882877

subject_name: PAEONIFLORIN


subject: CHEBI:57643


subject: CHEBI:16110


subject: PUBCHEM.COMPOUND:25223701

subject_name: PHOSPHATIDYLCHOLINE


subject: KEGG.COMPOUND:C00157

subject_name: Phosphatidylcholine


subject: CHEBI:61995

subject_name: Lecithin


subject: CHEBI:9144

subject_name: Silibinin


subject: CHEBI:125451

subject_name: silymarin


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine

object_name: pertussis


subject: UMLS:C0305065

object_name: Whooping cough


subject: UMLS:C0305065

object_name: diphtheria


subject: UMLS:C0305065

object_name: poliomyelitis


subject: UMLS:C0305065

object_name: hepatitis B


subject: UMLS:C0305065

object_name: tetanus


subject: UNII:8D7B37T28G

subject_name: SATRAPLATIN

object_name: neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: malaria


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: heart failure


subject: CHEBI:7915

object_name: congestive heart failure


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4745070

object_name: Embolism, Tumor


subject: UMLS:C4745070

object_name: Neoplasm Metastasis


subject: UMLS:C4745070

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C5555503

subject_name: Anti-CSF1R Monoclonal Antibody AMB-05X

object_name: colorectal cancer


subject: UMLS:C5555503

object_name: colorectal carcinoma


subject: UMLS:C5555503

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Inflammation


subject: CHEBI:34574


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: CHEBI:15367

subject_name: Tretinoin

object_name: sclerosing cholangitis


subject: MESH:C000612974

subject_name: PRG Barrier Coat

object_name: White spot lesions [initial caries] on smooth surface of tooth


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: Family history of dementia


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:2704

subject_name: Anastrozole

object_name: gynecomastia


subject: CHEBI:2704

object_name: Gynecomastia, CTCAE 5.0


subject: CHEBI:2704

object_name: Gynecomastia, CTCAE 3.0


subject: CHEMBL.COMPOUND:CHEMBL4594504

object_name: cytomegalovirus infection


subject: UMLS:C5815503


subject: CHEBI:8378

subject_name: Prednisolone

object_name: temporal arteritis


subject: CHEBI:8378

object_name: polymyalgia rheumatica


subject: UMLS:C5706395

subject_name: HSD-1 Inhibitor SPI-62


subject: UMLS:C5706395


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:28X28X9OKV

object_name: BRCA1 gene mutation


subject: UNII:28X28X9OKV

object_name: BRCA2 gene mutation


subject: UNII:28X28X9OKV

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent ovarian cancer


subject: UNII:28X28X9OKV

object_name: ovarian serous adenocarcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: diffuse large B-cell lymphoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: epilepsy


subject: CHEBI:76842

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:76842

object_name: obesity


subject: CHEBI:76842

object_name: Obesity, CTCAE


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:15676

subject_name: Allantoin

object_name: Cicatrization


subject: CHEBI:151315

subject_name: Heparin


subject: KEGG.COMPOUND:C00374


subject: CHEBI:70839

subject_name: Dasatinib

object_name: glioma


subject: CHEBI:70839

object_name: malignant glioma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:42567

subject_name: Fisetin


subject: CHEBI:42567


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: UNII:IK51552IFH

subject_name: Zytron

object_name: endometriosis


subject: UNII:P8CL89W8AP


subject: CHEBI:229727

subject_name: DMPA zwitterion


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: end stage renal failure


subject: CHEBI:39548

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor


subject: PUBCHEM.COMPOUND:11227182


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0919079

object_name: acute myeloid leukemia


subject: UMLS:C0919079

object_name: acute lymphoblastic leukemia


subject: UMLS:C0919079

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C0919079

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: UMLS:C0919079

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C0919079

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: UMLS:C0919079

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UMLS:C0919079

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: UMLS:C0919079

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C0919079

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C0919079

object_name: T-cell adult acute lymphocytic leukemia


subject: UMLS:C0919079

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C0919079

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UMLS:C0919079

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: UMLS:C0919079

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0919079

object_name: chronic myelomonocytic leukemia


subject: UMLS:C0919079

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:72564

subject_name: Temozolomide

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:72564

object_name: acute myeloid leukemia


subject: CHEBI:72564

object_name: acute lymphoblastic leukemia


subject: CHEBI:72564

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:72564

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:72564

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:72564

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:72564

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:72564

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:72564

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:72564

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:72564

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:72564

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:72564

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:72564

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:72564

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:72564

object_name: chronic myelomonocytic leukemia


subject: CHEBI:72564

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:62880

subject_name: Veliparib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:62880

object_name: acute myeloid leukemia


subject: CHEBI:62880

object_name: acute lymphoblastic leukemia


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: UMLS:C5238470

subject_name: Pegylated SN-38 Conjugate PLX038

object_name: medulloblastoma


subject: UMLS:C5238470

object_name: childhood medulloblastoma


subject: UMLS:C5238470

object_name: adult medulloblastoma


subject: UMLS:C5238470

object_name: glioma susceptibility 1


subject: UMLS:C5238470

object_name: ependymoma


subject: UMLS:C5238470

object_name: childhood ependymoma


subject: UMLS:C5238470

object_name: Newly Diagnosed Childhood Ependymoma


subject: UMLS:C5238470

object_name: Adult Ependymoma


subject: UMLS:C5238470

object_name: glioma


subject: UMLS:C5238470

object_name: malignant glioma


subject: UMLS:C3896794

object_name: pituitary tumor


subject: UMLS:C3896794

object_name: neoplasm


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:26710

object_name: obesity


subject: CHEBI:26710

object_name: Obesity, CTCAE


subject: CHEBI:38867

subject_name: anaesthetic

object_name: Anesthetics adverse reaction


subject: UMLS:C0002932

subject_name: Anesthetics


subject: UMLS:C4722058

subject_name: Anesthetics [TC]


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: adenomyosis


subject: UMLS:C1518041

object_name: Repeated implantation failure